Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 05 07 2018
revised: 01 10 2018
accepted: 14 11 2018
pubmed: 20 11 2018
medline: 14 1 2020
entrez: 20 11 2018
Statut: ppublish

Résumé

Diabetic kidney disease is characterized by increased albuminuria and/or a reduced glomerular filtration rate (GFR). We analyzed secular changes in the prevalence of albuminuria and reduced estimated GFR (eGFR) in Japanese patients with type 2 diabetes, and identified factors associated with these changes. Using 1996, 2001, 2006 and 2014 cohort data from the Japanese serial cross-sectional studies conducted at Shiga University of Medical Science, secular changes in the prevalence of diabetic kidney disease (albuminuria and/or reduced eGFR), patient characteristics and their associations were analyzed. The prevalence of microalbuminuria and macroalbuminuria decreased over time, whereas the prevalence of moderately reduced eGFR (30-60 mL/min/1.73 m During the past 20 years in Japan, the prevalence of albuminuria declined, whereas that of reduced eGFR increased. Additionally, obesity- and high age-related vascular damage seems to be associated with macroalbuminuria and reduced eGFR without macroalbuminuria, respectively.

Identifiants

pubmed: 30451386
doi: 10.1111/jdi.12977
pmc: PMC6626952
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1032-1040

Informations de copyright

© 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
PLoS One. 2014 Jun 27;9(6):e101219
pubmed: 24971671
Diabetes. 2007 Jun;56(6):1727-30
pubmed: 17360976
Diabetes Care. 2013 Oct;36(10):3227-33
pubmed: 23780946
J Diabetes Res. 2017;2017:7047909
pubmed: 28951879
Diabetes Care. 2018 Apr;41(4):775-781
pubmed: 29436384
BMJ Open Diabetes Res Care. 2018 May 29;6(1):e000521
pubmed: 29892340
Diabetes Care. 2013 Sep;36(9):2803-9
pubmed: 23620478
J Am Soc Nephrol. 2007 May;18(5):1540-6
pubmed: 17409317
J Diabetes Investig. 2010 Oct 19;1(5):212-28
pubmed: 24843435
Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964
pubmed: 29079252
Diabetologia. 2011 May;54(5):1025-31
pubmed: 21286682
Clin Exp Nephrol. 2014 Aug;18(4):613-20
pubmed: 24132561
JAMA. 2016 Aug 9;316(6):602-10
pubmed: 27532915
Diabetes Res Clin Pract. 1995 May;28(2):103-17
pubmed: 7587918
Lancet. 2010 Aug 7;376(9739):419-30
pubmed: 20594588
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
Diabetes Care. 2013 May;36(5):1248-53
pubmed: 23223350
J Diabetes Investig. 2019 Jul;10(4):1032-1040
pubmed: 30451386

Auteurs

Shinji Kume (S)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Shin-Ichi Araki (SI)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Satoshi Ugi (S)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Katsutaro Morino (K)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Daisuke Koya (D)

Department of Diabetology & Endocrinology, Kanazawa Medical University, Ishikawa, Japan.

Yoshihiko Nishio (Y)

Department of Diabetes and Endocrine Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Masakazu Haneda (M)

Department of Medicine, Asahikawa Medical University, Hokkaido, Japan.
Medical Corporation Kyousoukai, Osaka, Japan.

Atsunori Kashiwagi (A)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Kusatsu General Hospital, Kusatsu, Japan.

Hiroshi Maegawa (H)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH